A new at-home spit test for prostate cancer may be better than current blood tests, a new study shows. The simple saliva test has been developed by experts and works by analysing genetic variants in a ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc (VCYT). (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier ...
Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...
The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...
“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...
There is a 'large variation' between GP surgeries when it comes to the use of a prostate cancer test for men who have no signs of the disease, according to a study. The prostate-specific antigen (PSA) ...
The Decipher Prostate test is already widely used in the US to help identify localised prostate cancer more likely to spread. It becomes the first molecular test with clinical evidence from a ...
Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.
The Advertising Standards Authority (ASA) has prohibited advertisements for prostate supplements and home testing kits, fearing they could mislead vulnerable individuals or deter them from appropriate ...